High-Tech Gründerfonds

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Daniela Bach

Principal and Authorized Signatory

Kay G. Balster

Senior Investment Manager

Jens Baumgärtner

Principal and Authorized Signatory

Gernot Berger

Investor

Kilian von Berlichingen

Investor

Anke Cassing

Principal

Tanja Emmerling

Partner

Caroline Fichtner

Senior Investment Manager

Yann Fiebig

Investment Manager

Alexander von Frankenberg

Managing Director and Founder

Bernd Goergen

Partner

Stefanie Grüter

Partner, Communications and Relations

Gregor Haidl

Principal / Authorised Signatory

Frank Hensel

Senior Investment Manager

Olaf Joeressen

Senior Investment Manager

Markus Kressmann

Partner

Maurice Kügler

Investment Manager

Klaus Lehmann

Senior Investment Manager

Dominik Lohle

Senior Investment Manager

Torsten Löffler

Principal ppa. - DeepTech Future Fonds

Fabian Mohr

Investor

Martin Möllmann

Investment Manager

Axel Nitsch

Investment Manager

Andreas Olmes

Principal and Authorized Signatory

Katharina Peters

Investment Manager

Tilmann Petersen

Investment Manager

Claudia Raber

Partner

Nikolaus Raupp

Investor

Frank Reinecke

Partner

Guido Schlitzer

Managing Director

Ulrich Schmitt

Principal

Romy Schnelle

Partner

Tobias Schulz

Principal and Authorized Signatory

Katharina Severin

Investment Manager

Niels Sharman

Investor

Esko Stahl

Investment Manager

Björn Sykora

Principal and Authorized Signatory

Angelika Vlachou

Partner

Johannes Weber

Principal

Marco Winzer

Partner

Julian Zachmann

Investor

Christian Ziach

Principal and Authorized Signatory

Markus Kückelhaus Ph.D

Partner, Industrial Tech Team

Past deals in Series A

Dualyx

Series A in 2023
Dualyx specializes in the discovery and development of biological therapies aimed at treating autoimmune and rare diseases. The company focuses on creating immune modulators, particularly Treg-targeted therapies, which are designed to suppress unwanted autoimmune reactions in patients. By advancing these innovative treatments, Dualyx aims to provide lasting solutions for individuals suffering from autoimmune diseases, ultimately enabling medical professionals to offer effective cures.

Mbiomics

Series A in 2023
Operator of a microbiome research firm intended to transform microbiome research, diagnostics and therapeutics. The company delivers a high-throughput low-cost platform for dynamic and real-time analysis and quantification of the human gut microbiome, offering informed precision diagnostics and targeted therapies, enabling patients to improve their lives through novel approaches to lead a healthy life.

Kranus Health

Series A in 2022
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Code Intelligence

Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Venly

Series A in 2022
Arkane takes care of the complexity so you can offer a Web 2.0 experience while using the power of blockchain under the hood

Neural Concept

Series A in 2022
Neural Concept is a software company that employs deep learning algorithms to transform the industrial engineering process. This allows companies to focus on core strategic design choices, speed up R&D cycles, and reduce computational costs. The company was established in 2018 and is based in Lausanne, Switzerland.

Sunvigo

Venture Round in 2022
Sunvigo specializes in making solar power accessible to residential homeowners by offering affordable rooftop solar solutions. The company simplifies the process of using solar energy by collaborating with a network of partners, which includes smart meter operators and photovoltaic installers. Sunvigo enables customers to either purchase or rent solar systems, thereby promoting the use of local and emission-free energy. In addition to providing solar power generated from rooftops, the company offers real green power sourced from the grid, further supporting its commitment to sustainable energy solutions.

INERATEC

Series A in 2022
Provider of sustainable e-fuels and synthetic chemical products intended to replace fossil crude oil. The company specializes in producing renewable hydrogen and greenhouse gases such as carbon dioxide and hydrogen which are then converted into e-kerosene, carbon dioxide-neutral diesel, synthetic waxes, or methanol, enabling chemical plant operators to run their entire chemical plants using synthetic fuels using climate-neutral energy with reduced chemical waste and more climate protection.

Ceregate

Series A in 2022
CereGate GmbH, founded in 2019 and headquartered in Hamburg, Germany, with an additional office in San Diego, California, focuses on developing innovative brain-machine interface technology. The company's software platform enhances the programming of neuromodulation systems, including implants placed in the brain or spinal cord. This technology aims to support patients with neurological disorders or sensory deficits by enabling novel therapeutic approaches and improving their ability to adapt and manage their conditions independently. CereGate's advancements pave the way for new communication methods and therapeutic options, contributing to significant improvements in patient outcomes.

Blickfeld

Series A in 2021
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.

Emergence Therapeutics

Series A in 2021
Emergence Therapeutics AG develops novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The company was incorporated in 2019 and is based in Duisburg, Germany.

Abalos Therapeutics

Series A in 2021
Abalos Therapeutics GmbH is a biotechnology company based in Essen, Germany, focused on developing innovative immuno-oncology therapeutics. Founded in 2019, the company specializes in arenavirus-based drug candidates aimed at stimulating immune responses to target primary tumors and metastases. Utilizing its proprietary Fast Evolution platform, Abalos Therapeutics generates virus strains with optimized anti-tumoral properties. The company's approach involves reprogramming the immune system to effectively identify and eliminate malignant tumor tissue, thereby offering potential new treatment options for cancer. Through its novel immuno-virotherapy, Abalos Therapeutics seeks to harness the full capabilities of the immune system specifically against cancer cells.

Workpath

Series A in 2021
Workpath is the leading enterprise software provider enabling organizations to execute their strategies fast, flexible and effective in an increasingly dynamic and complex world. With simple and intuitive workflow tools Workpath engages all employees in the strategy and execution process. Its comprehensive analytics suite empowers executives to make better decisions on when to adapt focus, budgets or structures as early as possible.

Urban Ground

Series A in 2021
End to end digital lettings services fostering Tenancy as a Service

Qnami

Series A in 2021
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.

Sdui

Series A in 2021
Sdui GmbH, founded in 2017 and based in Koblenz, Germany, offers a digital platform designed to enhance communication within educational institutions. The platform simplifies interactions between teachers, parents, and students by providing features such as messaging, class schedules, parent letters, and room bookings. By digitizing essential processes, Sdui aims to reduce administrative burdens and improve organizational efficiency in schools. Over a short period, the company has gained traction in the educational market, reaching hundreds of institutions and establishing a strong reputation for its user-friendly solutions.

Actitrexx

Series A in 2021
Developer of a cell therapy technology designed for the treatment of patients after a stem cell transplant to prevent rejection reactions. The company's technology focuses on the development of clinical testing of cell therapeutics for the suppression of transplant rejection and autoimmunity and the portfolio of cell therapy, enabling patients to prevent the fatal consequences of rejection, significantly improving their quality of life, and also opening up to many therapy options.

GeneQuine Biotherapeutics

Series A in 2021
GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

Filestage

Series A in 2021
Filestage GmbH, founded in 2015 and based in Stuttgart, Germany, offers a web application designed to facilitate the review and approval of media content, including videos, designs, and documents. The platform enables users to share files with clients and colleagues, gather visual feedback, and manage the approval process without requiring reviewers to sign up. Filestage streamlines communication by allowing users to annotate comments directly within the files, thus eliminating the inefficiencies of email exchanges. The application includes features for tracking review statuses, managing revisions, and automating to-do lists, making it particularly useful for advertising agencies, video production studios, designers, consulting firms, and brands globally.

talpasolutions

Series A in 2020
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Taxdoo

Series A in 2020
Taxdoo is a startup that bills itself as a compliance platform for the digital economy. Its platform collects relevant data from marketplaces, online shops, and ERP systems on a daily basis and processes it in line with international VAT regulations, respective of financial authorities through an international network of VAT experts, which can then be transferred into financial accounting systems. The company was founded in 2016 and is headquartered in Hamburg, Germany.

Synendos Therapeutics

Series A in 2020
Synendos Therapeutics AG is a biopharmaceutical company based in Allschwil, Switzerland, founded in 2019. The company focuses on developing innovative therapies for unmet needs in neuropsychiatric disorders, particularly anxiety, mood, and stress-related conditions. Synendos utilizes a novel drug target within the endocannabinoid system to restore the brain's natural functioning. Its therapies involve the modulation of cannabinoid activity and the inhibition of endocannabinoid transport across cell membranes, addressing altered neurotransmission in various brain regions. This approach presents a promising solution to the significant demand for effective pharmacological treatments, especially for conditions like post-traumatic stress disorder (PTSD), which currently lacks adequate therapeutic options.

Troy

Series A in 2020
Troy GmbH, founded in 2017 and based in Lippstadt, Germany, is a FinTech company specializing in a debt collection platform designed to enhance customer experience. Operating as a subsidiary of TROY Group, Inc., Troy offers a service referred to as Friendly Debt Collection, which emphasizes a data-driven, omnichannel approach to engage customers effectively. The platform aims to preserve relationships between creditors and customers, recognizing that many customers may simply forget to pay or face temporary financial difficulties. By leveraging advanced technology, marketing, and customer relationship management, Troy has positioned itself as a leader in Europe’s debt collection sector, demonstrating a notable increase in debt recovery rates compared to traditional agencies. The service not only facilitates faster payments but also fosters positive customer sentiments, achieving an average customer satisfaction rating of 4.1 out of 5. Troy primarily targets corporate clients, providing tools that also enhance digitization and customer experience in internal processes.

heartbeat medical

Series A in 2020
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.

Ceregate

Series A in 2020
CereGate GmbH, founded in 2019 and headquartered in Hamburg, Germany, with an additional office in San Diego, California, focuses on developing innovative brain-machine interface technology. The company's software platform enhances the programming of neuromodulation systems, including implants placed in the brain or spinal cord. This technology aims to support patients with neurological disorders or sensory deficits by enabling novel therapeutic approaches and improving their ability to adapt and manage their conditions independently. CereGate's advancements pave the way for new communication methods and therapeutic options, contributing to significant improvements in patient outcomes.

Remind.me

Series A in 2020
Remind.me GmbH operates an online platform that offers reminder and optimization services specifically for contracts and insurance policies. Founded in 2017 and based in Berlin, the service allows users to input their contractual information, set reminders for expiry dates, and receive notifications about opportunities to optimize their contracts. Additionally, the platform provides access to online deals for various products and services, including the most affordable electricity and gas tariffs. The service is free for consumers, as it generates revenue through agency commissions from partners when users choose to finalize contracts. Remind.me aims to help users save money by ensuring they are aware of contract deadlines and can access the best available deals in the market.

stimOS

Series A in 2020
stimOS GmbH develops a drug delivery biochemical procedure that initiates bone formation, anti inflammatory activity, and healing process. The company also develops technologies and procedures that refine, functionalize, and activate implant materials. It also offers research and development of implant materials and implant surfaces. stimOS GmbH was founded in 2015 and is based in Constance, Germany.

Tubulis

Series A in 2020
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients.

NovaPump

Series A in 2020
NovaPump GmbH, based in Jena, Germany, specializes in the research, development, and distribution of non-invasive and percutaneous heart assist devices. Established in 2012, the company is focused on its innovative PERKAT technology, a self-expanding heart pump designed for acute left or right heart failure patients. This device will be available in the forms of pLVAD and pRVAD heart pumps, integrating with existing intra-aortic balloon pump techniques to enhance treatment options. The PERKAT system is notable for being catheter-based, pulsatile, and ECG-triggered, offering a cost-effective solution with high pump performance. Although the device is not yet on the market, it has been the subject of scientific publications and presentations at major cardiology conferences, highlighting its medical necessity and technological advantages. The company's mission is to provide timely and effective treatment for patients suffering from severe heart conditions, ultimately improving their chances of recovery.

Kumovis

Series A in 2020
Kumovis GmbH is a medical technology company based in Munich, Germany, that specializes in the manufacture of 3D-printing systems for medical applications. Founded in 2017, the company has developed the KUMOVIS R1, a 3D printing system that utilizes fused layer manufacturing for thermoplastic materials. Kumovis's systems are designed to produce a wide range of medical products, from prototyping to personalized human implants, and they emphasize clean room integration in their 3D printing processes. This focus on advanced printing technology allows Kumovis to cater to both industrial and medical sectors, enhancing the capabilities and customization of medical devices.

Noscendo

Series A in 2020
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.

Blickfeld

Series A in 2020
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.

Scipio Bioscience

Series A in 2020
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.

instagrid

Series A in 2020
Instagrid GmbH, founded in 2018 and based in Stuttgart, Germany, specializes in the manufacture of portable battery storage solutions. The company develops software-defined battery systems designed to provide advanced portable power supplies. Its products cater to various sectors, including construction, event technology, professional landscaping, garden and tree care, and public services, addressing the need for reliable and efficient power sources in diverse applications.

Selfapy

Series A in 2020
Selfapy GmbH is a Berlin-based company that provides online therapy programs aimed at individuals experiencing mental health challenges, particularly depression. Founded in 2016, Selfapy offers a range of therapy-related services, including programs focused on anxiety, eating disorders, stress management, and chronic panic. The company utilizes a guided self-help approach, allowing users to engage with exercises, videos, and texts over a three-month period, facilitated through phone or SMS interactions. These programs are designed to help users recognize negative thought patterns and develop healthier behaviors, all while ensuring anonymity and flexibility in the therapeutic process. Selfapy serves as a supportive tool for those seeking to improve their mental well-being.

envelio

Series A in 2019
Envelio GmbH, founded in 2017 and based in Cologne, Germany, specializes in developing software and algorithms for energy networks. Its primary offering is the Intelligent Grid Platform (IGP), a modular software system designed to assist distribution grid operators in digitizing and automating grid planning and operation processes. The IGP includes applications for data quality, which connects isolated data systems to identify and correct errors, as well as planning applications that automate grid planning tasks. Additionally, IGP operation applications provide recommendations for managing congestion in the grid during potential bottlenecks. By leveraging artificial intelligence and mathematical optimization, Envelio supports the integration of numerous distributed energy resources and smart meter data, addressing the challenges posed by the evolving energy landscape.

Troy

Series A in 2019
Troy GmbH, founded in 2017 and based in Lippstadt, Germany, is a FinTech company specializing in a debt collection platform designed to enhance customer experience. Operating as a subsidiary of TROY Group, Inc., Troy offers a service referred to as Friendly Debt Collection, which emphasizes a data-driven, omnichannel approach to engage customers effectively. The platform aims to preserve relationships between creditors and customers, recognizing that many customers may simply forget to pay or face temporary financial difficulties. By leveraging advanced technology, marketing, and customer relationship management, Troy has positioned itself as a leader in Europe’s debt collection sector, demonstrating a notable increase in debt recovery rates compared to traditional agencies. The service not only facilitates faster payments but also fosters positive customer sentiments, achieving an average customer satisfaction rating of 4.1 out of 5. Troy primarily targets corporate clients, providing tools that also enhance digitization and customer experience in internal processes.

Abalos Therapeutics

Series A in 2019
Abalos Therapeutics GmbH is a biotechnology company based in Essen, Germany, focused on developing innovative immuno-oncology therapeutics. Founded in 2019, the company specializes in arenavirus-based drug candidates aimed at stimulating immune responses to target primary tumors and metastases. Utilizing its proprietary Fast Evolution platform, Abalos Therapeutics generates virus strains with optimized anti-tumoral properties. The company's approach involves reprogramming the immune system to effectively identify and eliminate malignant tumor tissue, thereby offering potential new treatment options for cancer. Through its novel immuno-virotherapy, Abalos Therapeutics seeks to harness the full capabilities of the immune system specifically against cancer cells.

Remind.me

Series A in 2019
Remind.me GmbH operates an online platform that offers reminder and optimization services specifically for contracts and insurance policies. Founded in 2017 and based in Berlin, the service allows users to input their contractual information, set reminders for expiry dates, and receive notifications about opportunities to optimize their contracts. Additionally, the platform provides access to online deals for various products and services, including the most affordable electricity and gas tariffs. The service is free for consumers, as it generates revenue through agency commissions from partners when users choose to finalize contracts. Remind.me aims to help users save money by ensuring they are aware of contract deadlines and can access the best available deals in the market.

Remind.me

Series A in 2019
Remind.me GmbH operates an online platform that offers reminder and optimization services specifically for contracts and insurance policies. Founded in 2017 and based in Berlin, the service allows users to input their contractual information, set reminders for expiry dates, and receive notifications about opportunities to optimize their contracts. Additionally, the platform provides access to online deals for various products and services, including the most affordable electricity and gas tariffs. The service is free for consumers, as it generates revenue through agency commissions from partners when users choose to finalize contracts. Remind.me aims to help users save money by ensuring they are aware of contract deadlines and can access the best available deals in the market.

MoBerries

Series A in 2019
MoBerries GmbH operates an online platform that connects recruiters and candidates, aiming to transform traditional recruitment methods. Founded in 2015 and based in Berlin, Germany, the company utilizes a real-time matching algorithm to streamline the hiring process. The platform helps employers efficiently source high-quality candidates while minimizing time and resource expenditure. For job seekers, MoBerries offers access to tailored opportunities based on their skills and competencies, enhancing their chances of finding suitable positions. By leveraging artificial intelligence, MoBerries facilitates effective communication between employers and candidates, ensuring a more efficient and optimized hiring experience for both parties.

Alentis Therapeutics

Series A in 2019
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Cytena

Series A in 2019
cytena GmbH develops a laboratory device to separate single cells. Its products include singlecell printer, c.sight, b.sight, f.sight, and cartridge. The company offers its single cell printer technology for applications in cell line development, single cell genomic, and application development, including research and development aspects. The company was founded in 2014 and is headquartered in Freiburg, Germany with distribution networks in Europe, North America, India, Asia, and the United Kingdom. As per the transaction announced on August 5, 2019, cytena GmbH operates as a subsidiary of Cellink AB (publ).

IPlytics

Series A in 2019
IPlytics GmbH is a Berlin-based company that offers an online patent analytics platform designed to help organizations analyze market developments, technology trends, and competitive positions related to patenting and standardization. Founded in 2012 by a multidisciplinary team of economists, data scientists, and computer engineers, the platform integrates various data sources to map patents, technology standards, and related products. It provides users with insights into standard essential patents, patent licensing terms, and patent pools, facilitating informed decision-making in areas such as patent positioning, investments, portfolio planning, and emerging technologies. The platform employs advanced methods like Natural Language Processing and machine learning to enable efficient searching and analysis of technology landscapes, thereby assisting organizations, especially those with limited resources, in monitoring legal risks and identifying innovative business opportunities.

Gridscale

Series A in 2019
gridscale GmbH is a cloud computing provider based in Bedburg, Germany, specializing in Infrastructure as a Service (IaaS) solutions for both businesses and individual developers. Founded in 2014, the company offers a highly automated platform that allows users to manage cloud servers and customize infrastructure resources according to their specific needs. Their services include virtual cloud servers, storage, network resources, and complementary Platform as a Service (PaaS) components such as load balancers and firewalls. gridscale’s architecture is designed to integrate seamlessly into existing corporate systems, enabling clients to focus on their core business activities without the complexities of managing cloud infrastructure. This approach is particularly valuable in an era of increasing data complexity and volume.

Iconic Lab

Series A in 2019
Iconic Lab Holding GmbH, founded in 2017 and based in Frankfurt, Germany, focuses on sourcing, funding, developing, and accelerating startups in the crypto and blockchain sectors. The company supports these ventures through their initial coin offerings (ICOs) and token sales. Iconic Lab envisions a tokenized economy where blockchain technology fosters inclusive, transparent, and secure financial markets. By bridging the gap for enterprise-grade crypto asset investment opportunities, Iconic Lab enhances the tokenization of both financial and real-world assets. With a team experienced in digital assets and blockchain, the company aims to provide quality assurances expected by investors, while promoting its mission to decentralize wealth generation.

Mecuris

Series A in 2019
Mecuris GmbH, founded in 2016 and based in Munich, Germany, specializes in the development and supply of custom orthopedic aids, including orthoses and prostheses. The company empowers orthopedic and prosthetic (O&P) professionals through its Mecuris Solution Platform, which integrates digital technology and 3D printing. This platform allows for the co-creation of individualized O&P products by utilizing patient data and scans to semi-automatically generate custom 3D designs. These designs can be printed locally, ensuring a tailored fit and reducing production times by up to 75%. Mecuris aims to enhance the lives of wearers by providing quick, personalized solutions that meet their specific needs.

Atriva Therapeutics

Series A in 2019
Atriva Therapeutics GmbH, founded in 2015 and based in Tübingen, Germany, is a biopharmaceutical company dedicated to developing antiviral therapies for respiratory viral infections, including seasonal and pandemic influenza. The company focuses on its lead product, ATR-002, a Mitogen-activated protein kinase inhibitor that targets host cells to inhibit viral replication while also modulating the immune response. Atriva has completed preclinical development for ATR-002 and is seeking guidance from European regulatory authorities to proceed with a Phase I study in healthy volunteers. The company aims to address significant unmet medical needs associated with RNA virus infections, which place a substantial burden on healthcare systems globally.

PreOmics

Series A in 2018
PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.

Volterion

Series A in 2018
Volterion GmbH manufactures and sells compact size redox flow batteries for private homes for the storage of renewable energies. The company offers redox flow stacks, redox flow modules, and redox flow systems. The company was founded in 2015 and is headquartered in Dortmund, Germany.

Wirelane

Series A in 2018
Wirelane is a full service provider in the field of electric mobility. The company is currently active in 5 countries (D, F, S, NL, CH) and has experience with large industrial customers (VW, Vattenfall, Bouygues and others). In addition to their software solutions, they also offer specially developed charging stations that set standards through the use of advanced technology such as radar sensors and tap payment. The company works with customers from all industry sectors to develop solutions for tomorrow’s mobility needs. Wirelane is one of Europe’s leading specialist providers of hardware, software and app solutions.

VirtualQ

Series A in 2018
virtualQ GmbH, founded in 2014 and based in Berlin, Germany, specializes in providing innovative call waiting services for call centers and hotlines. The company offers a Call-In and Call-Back solution that effectively eliminates waiting times, balancing excellent customer service with cost efficiency. During peak periods, virtualQ holds the caller's place in line when wait times exceed a specified threshold. Callers receive notifications when it is their turn and are subsequently connected to the next available agent. The virtualQ service is accessible through various platforms, including voice, web, and mobile applications, enhancing the overall customer experience.

Soley

Series A in 2018
Soley GmbH is a software development company based in Munich, Germany, focused on engineering analytics. Founded in 2013 as a spin-off from the Technical University of Munich, Soley offers a range of software solutions including Modeler for domain-specific modeling and analysis, Soley Desk for self-service data intelligence, and Soley Studio for data quality enhancement and visualization. These tools are designed to streamline complex data handling and automate workflows in various sectors such as automotive, medical equipment, and IT. Soley’s applications support areas like product management, test case management, and decision-making processes, enabling businesses to efficiently manage their product portfolios and optimize operations. The company's innovative approach to data analysis has positioned it as a valuable partner for organizations seeking to enhance their engineering processes.

Casavi

Venture Round in 2018
casavi GmbH is a Munich-based company that operates a digital customer engagement platform specifically designed for property management and residential real estate companies. The platform serves as a customer communication and service portal, enabling these organizations to interact with their clients more effectively and efficiently. By leveraging various digital channels, including mobile, web, and email, casavi facilitates both inbound and outbound communication, acting as a virtual front desk. The solution integrates seamlessly with existing enterprise resource planning (ERP) and customer relationship management (CRM) systems, enhancing workflows and synchronizing data to improve overall customer service.

Userlane

Series A in 2018
Userlane GmbH, founded in 2015 and based in Munich, Germany, specializes in automating user onboarding and employee training through its innovative software navigation solution. The company offers interactive guides that enable organizations to train and assist employees effectively, enhancing trial conversion rates, reducing support costs, and increasing user engagement. Userlane's technology allows businesses to create step-by-step guides quickly, without requiring coding or modifications to existing software. This flexibility enables online companies to seamlessly implement interactive guidance throughout their platforms, streamlining the onboarding process and optimizing user experience. Userlane primarily serves SaaS providers, customer care managers, and employers looking to enhance their training capabilities.

Asana Rebel

Series A in 2018
Asana Rebel offers a Yoga-inspired fitness app combining the best of Yoga and fitness. The mobile fitness App is available in six languages (DE, EN, FR, PT, ESP, IT), has been featured multiple times by Apple and Google and is rated as one of the top health and fitness apps, with an average of more than 4.6 / 5 stars. The startup was founded in 2015 by Pascal Klein and Robin Pratap and is based in Berlin.

node.energy

Venture Round in 2017
node.energy GmbH is a software-as-a-service company that specializes in the optimization of local energy micro grids for commercial and industrial real estate. Founded in 2016 and headquartered in Frankfurt am Main, Germany, node.energy provides the opti.node application, which enables businesses with on-site power generation to effectively reduce energy costs and minimize their carbon dioxide emissions. The company's solutions support energy managers and metering service providers by significantly reducing administrative burdens and ensuring compliance with current regulations. Additionally, node.energy offers features such as electricity tax relief analysis and automated reporting, alongside planning and advisory services, to facilitate companies' energy transitions and enhance their operational efficiency.

MessengerPeople

Series A in 2017
MessengerPeople GmbH, founded in 2015 in Munich, Germany, specializes in software solutions for messenger communication, enabling businesses to interact with customers through popular messaging apps such as WhatsApp, Facebook Messenger, Apple Business Chat, Telegram, and Viber. The company, originally named WhatsBroadcast GmbH, rebranded in July 2018 and has since established itself as a leading Software-as-a-Service provider in the professional messenger services sector. MessengerPeople's platform allows for efficient management of customer inquiries while ensuring compliance with data protection regulations. Serving a diverse clientele, the company supports approximately 1,800 organizations, including businesses, cities, communities, associations, and political parties across more than 60 countries. With a team of 65 employees from 12 different countries, MessengerPeople continues to innovate in the field of customer communication.

cloudplan

Series A in 2017
cloudplan GmbH is a Hamburg-based company that specializes in developing a Software-as-a-Service application aimed at enhancing data management for businesses. Its solution facilitates the creation of private network storage, enabling companies to organize backups and integrate cloud storage effortlessly. cloudplan's offerings include advanced file storage, global clustering, and features for collaboration, task management, and workflow automation. The application is adaptable to various environments, including cloud, on-premise, hybrid, and multi-cloud setups. With an emphasis on security and ease of use, cloudplan's platform allows organizations to synchronize, share, and store data efficiently, minimizing the need for specialized IT expertise. The company's AI-powered technology simplifies corporate IT operations related to file syncing and sharing, ensuring secure data transfer across local networks and global cloud storage.

Volterion

Series A in 2017
Volterion GmbH manufactures and sells compact size redox flow batteries for private homes for the storage of renewable energies. The company offers redox flow stacks, redox flow modules, and redox flow systems. The company was founded in 2015 and is headquartered in Dortmund, Germany.

Cardior

Series A in 2017
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a specific microRNA, which serves as a molecular master switch regulating pathological changes in the heart due to stress or injury. Cardior Pharmaceuticals is committed to discovering and clinically validating innovative therapies that address the underlying causes of cardiac dysfunction, ultimately striving to improve patients' health and quality of life.

KSK Diagnostics

Series A in 2017
KSK Diagnostics GmbH, established in 2014 and based in Hamburg, Germany, specializes in the development of molecular point-of-care diagnostic assays aimed at diagnosing infectious diseases and cancer. The company utilizes isothermal amplification technology to create rapid tests that enable healthcare professionals to make timely diagnoses, often within 30 minutes, thereby facilitating prompt treatment decisions. In addition to its diagnostic assays, KSK Diagnostics offers customizable services, including the development of nucleic acid-based tests using real-time PCR or RT-PCR, as well as verification and validation studies and product enhancement services for other organizations in the healthcare sector. As a pioneer in this field, KSK Diagnostics is dedicated to improving patient-oriented diagnostics through innovative technologies.

fodjan GmbH

Series A in 2017
fodjan GmbH, founded in 2014 and based in Dresden, Germany, specializes in providing feed management and ration calculation software tailored for dairy farmers and consultants. The company's flagship software solution, also named fodjan, assists users in planning feed stocks and rations, presenting clear options for their dairy operations. It evaluates the healthiness of various rations and offers scientifically backed recommendations for improvement. The platform is designed for use by both independent dairy farmers and consulting firms, allowing consultants to manage multiple enterprises from a single account while accessing valuable insights and analytics to enhance animal health and optimize costs.

HepaRegenix

Series A in 2016
HepaRegeniX GmbH, founded in 2016 and based in Ulm, Germany, focuses on developing innovative drugs for the treatment of acute and chronic liver diseases. The company’s approach centers on the mitogen-activated protein kinase (MAPK) pathway, specifically targeting MAP kinase kinase 4 (MKK4), a crucial regulator of liver regeneration. Research conducted by Professor Lars Zender and his team at the University Hospital Tübingen has demonstrated that small RNA molecules can suppress MKK4 gene expression, thereby restoring the regenerative capacity of hepatocytes even in severely diseased livers. HepaRegeniX is advancing the development of small-molecule MKK4 inhibitors, which have the potential to address liver disorders, including nonalcoholic steatohepatitis, by enhancing liver regeneration.

AudioCure

Series A in 2016
AudioCure Pharma GmbH develops drugs for neurodegenerative disease indications. AudioCure Pharma GmbH was incorporated in 2010 and is based in Berlin, Germany.

VMRay

Series A in 2016
VMRay GmbH specializes in developing advanced software for malware analysis and detection, utilizing innovative hardware virtualization techniques. Founded in 2013 and based in Bochum, Germany, the company offers a suite of products, including VMRay Analyzer for comprehensive malware analysis, VMRay Detector for automated threat detection, VMRay Investigator for digital forensics, and VMRay Email Threat Defender to combat phishing attacks. The VMRay Platform features an agentless, hypervisor-based sandbox that provides high evasion resistance and complete visibility into malware behavior, allowing organizations to accurately monitor and understand malicious activities without altering the analysis environment. This capability results in precise threat detection with minimal false positives, streamlining incident response and enhancing cybersecurity efficiency. VMRay's software empowers businesses to safeguard their assets and infrastructure while delivering critical intelligence for forensic analysis of intrusion attempts.

Immunic Therapeutics

Series A in 2016
Immunic Therapeutics is a clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Its primary product, IMU-838, is a selective immune modulator currently in Phase 2 clinical trials for ulcerative colitis, relapsing-remitting multiple sclerosis, and Crohn's disease. Additionally, the company is advancing IMU-935, an inverse agonist targeting RORgt, and IMU-856, which aims to restore intestinal barrier function in patients with conditions such as inflammatory bowel disease and irritable bowel syndrome. Immunic Therapeutics is headquartered in New York, New York, and seeks to provide effective treatment options for a range of chronic inflammatory conditions through its innovative drug development initiatives.

Rigontec

Series A in 2016
Rigontec GmbH is a biopharmaceutical company specializing in RNA-based immunotherapeutics aimed at treating cancer and viral diseases. Founded in 2014 and based in Planegg, Germany, the company focuses on developing compounds that activate the immune receptor retinoic acid-inducible gene I (RIG-I), specifically through its lead product, ImOl100. This compound acts as a minimal mimic of the naturally occurring 3pRNA motif found in viral RNAs, stimulating the immune response effectively. Rigontec's approach circumvents common challenges faced by traditional cancer therapies, such as vaccines and checkpoint inhibitors, by targeting RIG-I pathways to induce tumor cell death and promote long-term immunity. In 2017, Rigontec became a subsidiary of Merck & Co., Inc., enhancing its capabilities in the field of immuno-oncology.

Reactive Robotics

Series A in 2016
Reactive Robotics GmbH, founded in April 2015 in Munich, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's robots are specifically tailored for gait rehabilitation in neurological patients and for use in orthopedic patients recovering from joint replacement procedures. With a team that brings over a decade of experience in rehabilitation robotics and extensive startup knowledge, Reactive Robotics has established a robust clinical network to advance its innovations. The company benefits from a diverse group of advisors who offer guidance in engineering, legal matters, and the regulatory processes necessary for medical device registration, ensuring a comprehensive approach to its operations.

Cunesoft

Series A in 2016
Cunesoft GmbH is a provider of cloud-based regulatory compliance software solutions tailored for the life sciences industry. Established in 2013 and headquartered in Munich, Germany, with offices in Princeton, New Jersey, and Bengaluru, India, Cunesoft offers a range of Software as a Service (SaaS) products. These include cune-IDMP, a master data management tool for accessing external regulatory databases; cune-eCTD, which facilitates electronic submission creation; and cune-Track, a workflow management system for regulatory tasks. Additionally, the company provides cune-RDMS for document navigation and tagging, cune-SOP for standard operating procedures, and cune-Portal for sharing regulatory documents. Cunesoft also offers outsourcing services for regulatory procedures and documentation. The company’s software is designed for quick deployment and is utilized by both small and medium-sized enterprises and larger pharmaceutical divisions globally, emphasizing reliability, security, and compliance. Cunesoft operates as a subsidiary of Phlexglobal Ltd. since January 2020.

Amal Therapeutics

Series A in 2016
Amal Therapeutics SA is a biotech company based in Geneva, Switzerland, founded in 2012 as a spin-off from the University of Geneva. The company focuses on the research and development of therapeutic vaccines for oncology, utilizing its proprietary cell penetrating peptide platform. Amal Therapeutics aims to create innovative therapeutic cancer vaccines and immunotherapies to enhance treatment options for cancer patients. As of July 2019, Amal Therapeutics operates as a subsidiary of Boehringer Ingelheim GmbH.

Multiphoton Optics

Series A in 2015
Multiphoton Optics GmbH specializes in the development and sale of 3D printing equipment and software for additive manufacturing. The company's technology enables the creation of complex three-dimensional structures across various materials, including polymers, hybrid materials, glasses, and metals. Key products include the LithoProf3D printing platform, along with the LithoStream3D and LithoSoft3D software solutions, which cater to applications in photonics, biomedicine, life sciences, and functional materials. Additionally, Multiphoton Optics provides services such as prototyping, engineering support, and consulting to enhance customer experience. Founded in 2013 in Wurzburg, Germany, the company has established a reputation for high-precision opto-electronics assembly and innovative optical component packaging solutions.

figo

Series A in 2015
figo GmbH develops a software as a Service platform that aggregates financial data for financial institutions. It allows users to access the sources of finance, notification services, security, as well as user and customer management services. figo GmbH was founded in 2012 and is based in Hamburg, Germany. As of March 4, 2020, figo GmbH operates as a subsidiary of FinReach GmbH.

gestigon

Series A in 2015
gestigon GmbH, founded in 2011 and based in Lübeck, Germany, specializes in 3D image processing software for body and gesture recognition. The company develops middleware algorithms that utilize 3D depth sensors to track human poses, recognize gestures, and identify biometric features. Its solutions are predominantly applied in the automotive industry to enhance driver and passenger monitoring within vehicle cabins, as well as to improve cabin comfort and driving assistance. In addition, gestigon offers augmented reality and virtual reality interaction design services, enabling users to control electronic devices through gestures without physical contact. As of early 2017, gestigon operates as a subsidiary of Valeo SA, a leading global automotive supplier, which has facilitated the company's growth and expansion in the market.

eWings.com

Series A in 2015
eWings.com GmbH, a travel management company, offers a way to find, book, and manage flights, trains, and hotels via web and mobile. The company was founded in 2013 and is based in Berlin, Germany. As of June 8, 2017, eWings.com GmbH operates as a subsidiary of Hogg Robinson Group plc.

Juniqe

Series A in 2015
JUNIQE is the lifestyle brand for curated and affordable wall art, home accessories, stationery, and gifts. Their team of eCommerce professionals works to help customers make their houses their homes by bringing art into their everyday lives: Art. Everywhere. Seeking to engage and excite, JUNIQE's team searches the globe for emerging and established artists before handpicking artworks and printing these on selected merchandise. Its wide product portfolio includes premium posters, framed prints, shower curtains, cushions, personal planners and notebooks, to name a few. Guided by the vision of bringing art into every home, JUNIQE empowers and inspires its customers through exciting and affordable art.

FAZUA

Series A in 2015
FAZUA specializes in developing an e-Bike drive system. Its e-Bike drive system was designed to meet sportive demands and, at the same time to create a natural feeling of non-motorized bike riding. FAZUA was founded in 2013 and is headquartered in Ottobrunn, Bayern, Germany.

OMEICOS Therapeutics

Series A in 2015
OMEICOS Therapeutics GmbH is a biotechnology company focused on developing innovative therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. Established in 2013 and headquartered in Berlin, Germany, the company is pioneering a first-in-class small molecule that leverages a unique mode of action based on natural metabolites of omega-3 fatty acids. These metabolites exhibit strong anti-arrhythmic properties by activating an endogenous cardio-protective signaling pathway, which not only stabilizes heart rhythm but also aims to provide curative effects by preventing electrical and structural remodeling of the heart. OMEICOS' approach is designed to offer safe and effective treatment options for patients with cardiovascular conditions, while also addressing inflammatory diseases and other indications.

Sonormed GmbH

Series A in 2015
Sonormed GmbH is a medical technology company based in Hamburg, Germany, that specializes in digital audiology. Founded in 2012, the company has developed Tinnitracks, a web application designed to assist users in filtering music for tinnitus therapy, which is supported by neuroscientific research. This innovative solution not only helps users select appropriate music tracks for therapeutic purposes but also automatically evaluates the music files to assess their therapeutic potential, providing guidance on the suitability of each track for tinnitus treatment.

Skive

Series A in 2015
Skive is a startup focused on transforming mobile learning for students. It offers a digital education platform accessible from any device, allowing users to create and share multiple-choice questions to aid in exam preparation. The platform curates targeted learning content tailored for various university courses, developed by top students, ensuring users access high-quality study materials. In addition to academic resources, Skive connects students with potential employers, facilitating mobile employer branding opportunities for companies. This dual approach aims to enhance the educational experience while bridging the gap between students and the job market.

oncgnostics

Series A in 2015
oncgnostics GmbH develops molecular assays based on epigenetic biomarkers which allows early and reliable cancer diagnostics. It develops GynTect, which enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages; and in vitro diagnostic (IVD) tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics. The company was founded in 2012 and is based in Jena, Germany.

gestigon

Series A in 2014
gestigon GmbH, founded in 2011 and based in Lübeck, Germany, specializes in 3D image processing software for body and gesture recognition. The company develops middleware algorithms that utilize 3D depth sensors to track human poses, recognize gestures, and identify biometric features. Its solutions are predominantly applied in the automotive industry to enhance driver and passenger monitoring within vehicle cabins, as well as to improve cabin comfort and driving assistance. In addition, gestigon offers augmented reality and virtual reality interaction design services, enabling users to control electronic devices through gestures without physical contact. As of early 2017, gestigon operates as a subsidiary of Valeo SA, a leading global automotive supplier, which has facilitated the company's growth and expansion in the market.

Givve

Series A in 2014
Givve is a FinTech company that provides innovative benefit solutions aimed at enhancing employee motivation and engagement. In a competitive labor market characterized by challenges such as a skills shortage and changing employee expectations, Givve's offerings are designed to attract and retain talent. The company has developed a cashless card service that allows employees and business partners to access a voucher portal, enabling purchases of groceries and household products at reduced prices while also offering tax advantages. By focusing on employee benefits and motivation, Givve aims to help businesses improve their attractiveness in the job market and effectively compete for skilled workers.

Rigontec

Series A in 2014
Rigontec GmbH is a biopharmaceutical company specializing in RNA-based immunotherapeutics aimed at treating cancer and viral diseases. Founded in 2014 and based in Planegg, Germany, the company focuses on developing compounds that activate the immune receptor retinoic acid-inducible gene I (RIG-I), specifically through its lead product, ImOl100. This compound acts as a minimal mimic of the naturally occurring 3pRNA motif found in viral RNAs, stimulating the immune response effectively. Rigontec's approach circumvents common challenges faced by traditional cancer therapies, such as vaccines and checkpoint inhibitors, by targeting RIG-I pathways to induce tumor cell death and promote long-term immunity. In 2017, Rigontec became a subsidiary of Merck & Co., Inc., enhancing its capabilities in the field of immuno-oncology.

Inventorum

Series A in 2014
Inventorum GmbH, founded in 2012 and based in Berlin, Germany, specializes in developing a point of sale application for retailers and online businesses. The company's software is designed to assist small retailers in managing both their offline and online operations by streamlining daily processes, including point of sale and inventory management. Inventorum's integrated system combines cash management, inventory management, customer support, and e-commerce functionality, offering a comprehensive solution tailored to the needs of small businesses. As of July 2020, Inventorum operates as a subsidiary of Shore GmbH.

Quobyte

Series A in 2014
Quobyte GmbH, founded in 2013 and based in Berlin, Germany, specializes in software storage infrastructure services. The company's flagship product is Quobyte, a data center file system that transforms commodity servers into a unified, high-performance, and scalable storage solution. Quobyte's software supports various storage media, including HDDs, SSDs, and NVMes, and is designed to eliminate data silos by providing unified access with common authentication and access control lists. With its architecture inspired by Google's large-scale storage operations, Quobyte can efficiently scale to accommodate thousands of clients, servers, and volumes without downtime during resource expansion. The company was established by Felix Hupfeld and Björn Kolbeck, who leveraged their extensive experience in distributed and storage systems research to create a reliable and flexible software storage infrastructure tailored for diverse sectors, including life sciences and financial modeling.

Sablono

Series A in 2014
Sablono GmbH, founded in 2013 and based in Berlin, Germany, specializes in software solutions for the digital planning and management of construction projects. Its flagship product, Sablono Onsite, allows users to monitor and analyze project progress in real-time through detailed schedules that can be updated and verified on-site. This software enhances collaboration by enabling clients to track the status of deliverables and share crucial information efficiently. Sablono is recognized for its innovative approach, having won the first prize in the "IKT Innovativ" competition at CeBIT 2014, which was awarded by the German Federal Ministry for Economic Affairs. The company is also part of the SAP Start-up Focus Programme and receives support from notable partners including High-Tech Gründerfonds and Hasso Plattner Ventures.

ezeep

Series A in 2014
Ezeep GmbH provides a cloud-based print management solution designed for small and medium-sized enterprises. Founded in 2010 and based in Berlin, Germany, Ezeep enables users to manage printers and print documents through its online interface. The service supports wireless printing from various devices, including smartphones, tablets, and laptops, without the need for additional hardware. Ezeep has been a subsidiary of ThinPrint Cloud Services, Inc. since 2015, further enhancing its capabilities in the print management sector.

Desino

Series A in 2014
Desino, a Cologne, Germany-based provider of a wheelchair with dynamic seating system, These dynamic seating systems are already established in the office furniture industry and the company now aims to make this also available to people, who spent the most time in a seating posture.

Scopis

Series A in 2013
Scopis GmbH, founded in 2010 as a joint spin-off of Charité University Clinic Berlin and Fraunhofer IPK, specializes in developing and manufacturing navigation systems for minimally invasive surgeries, particularly in the fields of ENT, spine, cranio-maxillofacial, and neurosurgery. The company offers a range of products, including the Scopis TGS for navigated functional endoscopic sinus surgery and the Hybrid Navigation System, which integrates with endoscopic towers to provide high-definition documentation. Scopis also produces various EM instruments, such as precision pointers, malleable suction tubes, and tracking devices. Additionally, the company provides planning software that facilitates the surgical process by allowing users to create and execute plans in the operating theater. Scopis operates a worldwide distribution network and is based in Berlin, Germany, as a subsidiary of Stryker Corporation.

Itembase

Series A in 2013
Itembase GmbH, founded in 2011 and based in San Francisco, California, operates a cloud-based shopping manager that allows consumers to store and organize their products along with relevant information such as receipts and invoices. The platform also facilitates the sharing of purchases and experiences on social networks. Additionally, Itembase serves as an e-commerce API integration platform, connecting e-commerce shops with solution providers and enabling them to offer services across multiple shop systems. With over 120,000 e-commerce shops utilizing its services, Itembase focuses on providing tailored solutions that enhance the online shopping experience. The company also hosts, enriches, and provides product identity data, further supporting its role in the e-commerce ecosystem.

Middle Peak Medical

Series A in 2013
Middle Peak Medical is a privately held medical device company dedicated to developing innovative solutions for mitral valve disease. The company focuses on creating a proprietary device designed to address unmet needs in treating mitral valve regurgitation. This novel technology aims to restore mitral valve competence in both functional and degenerative conditions by providing a new posterior surface for the anterior leaflet to seal properly. The device is applicable in both percutaneous catheter-based interventions and minimally invasive or open-heart cardiac surgeries, positioning Middle Peak Medical as a key player in advancing treatment options for patients with mitral valve disorders.

PressMatrix

Series A in 2013
PressMatrix GmbH, based in Berlin, Germany, specializes in digital publishing services aimed at transforming traditional print media into interactive digital formats for various platforms, including tablets and mobile devices. Founded in 2009 and originally named bblabs UG, the company rebranded to PressMatrix GmbH in 2011. It provides a comprehensive publishing solution that includes subscription services, a Workbench for content management, and mobile applications tailored for magazines, books, journals, and catalogs. PressMatrix caters to a diverse clientele, including publishers, agencies, and enterprises, with notable clients such as Georg Thieme Verlag and Carry-On Publishing GmbH. The company employs a proprietary online PDF to app converter, enabling seamless conversion and distribution of content across multiple channels.

Ubermetrics

Series A in 2013
uberMetrics Technologies GmbH offers software as a service media monitoring solutions. The company offers UMT Delta, software as a service tool that connects media monitoring, press review, and crisis communication management from various media channels including TV, radio, print, and the social Web. uberMetrics Technologies GmbH was founded in 2011 and is based in Berlin, Germany.

HQ plus

Series A in 2013
HQ plus GmbH, founded in 2012 and based in Berlin, Germany, specializes in developing and marketing web applications for the hotel industry. The company's flagship product is a web-based rate shopping tool designed to meet the needs of hoteliers and revenue managers. This tool provides real-time updates on competitors' room rates, enabling users to make informed pricing decisions that can enhance revenue while saving time. It also integrates information on local trade fairs and events, allowing for strategic pricing adjustments based on demand. Additionally, the tool includes a parity check feature that helps users optimize their rates and availability across various online travel agencies. Designed by hoteliers for hoteliers, the application emphasizes intuitive use and clear data presentation.

Versus

Series A in 2013
Versus is a Berlin-based company that provides a platform for comparing a wide range of subjects, including smartphones and universities, through over 45 million natural language text comparisons in 18 languages. Since its inception in 2011, the platform has seen consistent growth, with traffic increasing by an average of 35% each month, currently attracting 3 million unique visitors monthly. Versus aims to establish itself as a comprehensive, Wikipedia-scale information resource for comparisons. The company has secured $3.8 million in funding from various investors, including Earlybird Venture Capital and others, and operates with a team of 30 employees under the leadership of CEO Ramin G. Far.

CardioSecur

Series A in 2013
CardioSecur, developed by Personal MedSystems GmbH, is a mobile ECG system designed for smartphone use that enables users to monitor heart rate and rhythm, as well as detect circulation disturbances such as infarctions. Founded in 2008 and based in Frankfurt am Main, Germany, the company focuses on creating innovative and user-friendly health monitoring solutions. CardioSecur specializes in advanced 12-lead ECG technology that utilizes a reduced number of electrodes, ensuring both sophistication and ease of use. The company's goal is to provide professional-grade ECG systems that can be integrated into personalized applications, making cardiac monitoring accessible to individuals.

CryoTherapeutics

Series A in 2013
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

Yorxs

Series A in 2013
Yorxs AG, based in Munich, Germany, specializes in the online sale of bulk diamonds and diamond jewelry. Founded in 2011, the company provides customers with access to a diverse selection of certified diamonds in various shapes and sizes, alongside a range of jewelry items such as rings, necklaces, pendants, and bracelets. Yorxs emphasizes customization by offering a wide array of configuration options for its products. The company also prioritizes transparency regarding the origins of its diamonds, allowing customers to make informed purchasing decisions from the comfort of their homes.

SOPAT

Series A in 2013
SOPAT is specialized in the analysis of particulate systems. Our team develops and markets an innovative particle measurement technology for real-time analysis of multi-phase systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.